Inhalation Sciences AB (ISAB) has signed a collaboration agreement with a leading Indian multinational pharma company with a powerful respiratory portfolio and a major presence in over 80 markets worldwide. The company has chosen DissolvIt,ISAB's in vitrodissolution and absorption module, for its Inhalation Research project. In the present collaboration, the company has chosen to use ISAB's research services to assess the dissolution properties of one of their inhalation drugs in their complex generics pipeline with the in vitro system DissolvIt.

DissolvIt is an advanced dissolution method designed specifically for inhaled substances generating data that better correlate with the properties of the same drugs in clinical trials on patients, so potentially reducing risk and costs.